中文名稱:化合物 MI-192 | 英文名稱:MI-192 |
CAS:1415340-63-4 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號: T21898 |
名稱 | MI-192 |
描述 | MI-192 is a selective HDAC2 and HDAC3 inhibitor with IC 50 s of 30 nM and 16 nM, respectively. MI-192 is more selective for HDAC2/3 than other HDAC isomers.MI-192 induces myeloid leukaemic cells apoptosis. MI-192 has potential use in leukaemia and anti-stroke [1] [2]. |
體外活性 | MI-192 (0.15-1 μM; 72 h) induces differentiation and is cytotoxic by promoting apoptosis in acute myeloid leukaemic cell lines U937, HL60 and Kasumi-1 [1]. Apoptosis Analysis [1] Cell Line: HL60 and Kasumi-1 cells Concentration: 150 nM, 300 nM, 500 nM, 1 μM Incubation Time: 72 h Result: Induced a substantial degree of apoptosis in both HL60 and Kasumi-1 cells. |
體內(nèi)活性 | MI-192 (40 mg/kg; i.p; once a day; for 3 days) exhibits the neuroprotective activity in the mouse brain subjected to photothrombotic stroke [2]. Animal Model: Adult male outbred mice CD-1 (20-25 g) with photothrombotic stroke (PTS) [2] Dosage: 40 mg/kg Administration: i.p; once a day; for 3 days Result: Reduced the volume of the PTS-induced infarction core in the mouse brain, partly restored the functional symmetry in the forelimb use, decreased the level of PTS-induced apoptosis and acetylation of α-tubulin characteristic for stable microtubules, and increased the expression of GAP-43 in the cerebral cortex of the damaged hemisphere. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
關(guān)鍵字 | MI192 | MI-192 | MI 192 |
成立日期 | 2013-04-18 (13年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2025-07-31 | |
詢價 |
VIP1年
|
上海切爾齊生物科技有限公司
|
2025-04-23 | |
詢價 |
VIP4年
|
紹興市均宇生物科技有限公司
|
2025-08-04 |